LEAH CHILDRESS: Open Payments
NPI 1023350097 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,039 in 128 payments from 23 companies in 2025. Trend: 2023 $3,320 · 2024 $3,041 · 2025 $3,039
Food & beverage: $2,980Consulting: $59
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $388 |
| Regeneron Healthcare Solutions, Inc. | 10 | $289 |
| Novartis Pharmaceuticals Corporation | 11 | $278 |
| GENZYME CORPORATION | 9 | $276 |
| CSL Behring | 13 | $244 |
| Ionis Pharmaceuticals, Inc. | 10 | $215 |
| Genentech USA, Inc. | 9 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $189 |
| PFIZER INC. | 6 | $171 |
| GlaxoSmithKline, LLC. | 8 | $164 |
Products named: DUPIXENT, XOLAIR, DAWNZERA, FASENRA, TEZSPIRE, NUCALA, AIRSUPRA, Hizentra.
Industry payments across VA — which companies pay providers there.
